Gemfibrozil

Overview

Gemfibrozil is an antihyperlipidemic agent that reduces cholesterol and triglyceride levels in the blood with a particular effect on reducing triglycerides and raising HDL cholesterol. It is primarily used to treat dyslipidemia and prevent cardiovascular disease.

API suppliers (19)

Suppliers of Gemfibrozil evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
• Isochem SasFrance1 active DMF
• Piramal Pharma LimitedIndia1 active DMF GMP on record
• TAPI NL BVNetherlands1 active DMF
• SOCIETA ITALIANA MEDICINALI SCANDICCI SIMS SRLItaly1 active DMF GMP on record
• Zhejiang Excel Pharmaceutical Company., Ltd.China1 active DMF
• Cadila Pharmaceuticals LimitedIndia1 active DMF GMP on record
• SHANGHAI SUNVE PHARMACEUTICAL CO LTD
• SHANDONG WEIFANG PHARMACEUTICAL FACTORY CO LTD
• Siegfried LTDUnited Kingdom
• RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPAItaly GMP on record
• SYMED LABS LTDIndia GMP on record
• SHANGHAI ZHONGXI SUNVE PHARMACEUTICAL CO LTDChina
• BLASCHIM SPA
• DINAMITE DIPHARMA SPA
• FRANCIS SPA
• GANES CHEMICALS INC PENNSVILLE DIV
• SIGNA SA DE CV
• SIBEFAT SPA

EU CEP holders (4)

Companies holding a valid EU Certificate of Suitability (CEP) for Gemfibrozil, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.

Therapeutic areas